1. Market Assessment: Great new product or just really cool science?MaRS BioEntrepreneurship Events Series November 13, 2006 2. In the beginning…At some stage all great…

1. Sorrento TherapeuticsNext-Generation Cancer Therapeutics January 2014 2. Safe Harbor StatementNASDAQ: SRNEThis presentation contains "forward-looking statements"…

1. INITIATING COVERAGEJuly 25, 2011VENTRUS BIOSCIENCES (VTUS) 22RATING:BUY 20BIOPHARMAPRICE: $11.8918 16PRICE TARGET:$24 14WILLIAM TANNER, PHD MARKET CAP:$156.0 [email protected]&P…

1. Paul K. Wotton, Ph.D. President and Chief Executive Officer December 2010 AMEX: AIS 2. Page 2 Safe Harbor Statement This presentation may contain forward-looking statements…

Slide 12014 FPWR Research Conference Keith Gottesdiener, MD CEO, Rhythm Pharmaceuticals November 2014 Slide 2 April 29, 2015 CONFIDENTIAL 2 Prader Willi Syndrome Ph2a 3Q-4Q15…

Slide 1 © 2009 Pharmaceutical Law Group PC Market Exclusivity Paradigm Gregory J. Glover, MD, JD Pharmaceutical Law Group [email protected] www.pharmalawgrp.com…